Corey Bloom

This inventor holds 33 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Deciphera Pharmaceuticals, LLC, Bend Research, Inc., Bristol-Myers Squibb Compnay. Active years: 2008-2026.

USPTO Granted Patents = 33 (Patent Applications = 9)

% Patents Active = 72.7

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 4.1

ph-index = 10

Forward Citations = 367(Granted Patents)

Company Filing History:

21 out of 99

Deciphera Pharmaceuticals, LLC

Bristol-Myers Squibb Compnay

patents

4. 1 out of 488

Colorado State University Research Foundation

Years Active: 2008-2026

Loading Chart...

Areas of Expertise:

Tyk2 Inhibitors

Amorphous Kinase Inhibitors

Pharmaceutical Compositions

Dextran Polymer Derivatives

Nanoparticles

Oral Formulations

Taste-Modified Formulations

Cationic Polymers

4-Methyl Compounds

Belinostat

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734169 - Dosage forms for Tyk2 inhibitors (2026-09-15),

2. 12708617 - AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF (2026-08-18),

3. 12521390 - Dosage forms for Tyk2 inhibitors (2026-01-13),

4. 12318374 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-06-03),

5. 12226406 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-02-18),

6. 12213968 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-02-04),

7. 12213967 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-02-04),

8. 12064422 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-08-20),

9. 12023328 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-07-02),

10. 11969415 - (methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-04-30),

11. 11918564 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-03-05),

12. 11911370 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-02-27),

13. 11903933 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-02-20),

14. 11896585 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea (2024-02-13),

15. 11850241 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2023-12-26),

Title: The Innovative Journey of Corey Bloom

Introduction

Corey Bloom, based in Bend, Oregon, is a prolific inventor with an impressive portfolio of 29 patents. His contributions to the field of pharmaceuticals, particularly in the development of targeted treatments, showcase his commitment to advancing medical science and improving patient outcomes.

Latest Patents

Among Corey’s latest innovations are two significant patents focusing on compositions involving a compound designated as 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea. These compositions are characterized by low impurity levels and are designed to treat disorders associated with the activity of c-KIT and PDGFRα kinases, as well as their oncogenic forms. This intricate work highlights Corey’s role in addressing critical health challenges and paves the way for new therapeutic avenues.

Career Highlights

Corey Bloom has made significant strides in the pharmaceutical industry, particularly through his roles at Deciphera Pharmaceuticals, LLC and Bend Research, Inc. His work at these organizations not only underscores his expertise in drug development but also emphasizes his impact on patented innovations that benefit healthcare.

Collaborations

Throughout his career, Corey has collaborated with talented professionals such as Scott Bone and Fred Jordan. These partnerships have allowed for the pooling of knowledge and expertise, enhancing the scope and effectiveness of their innovative projects, ultimately leading to meaningful advancements in their field.

Conclusion

Corey Bloom’s innovative spirit and dedication to scientific research are evident through his extensive patent portfolio and collaborative efforts. As he continues to push the boundaries of pharmaceutical development, his work serves as an inspiration and valuable asset to the medical community.